Celldex Therapeutics, Inc
$29.33
USD
Last updated on --.
24h volume490.42K
24h highest30.3450 USD
24h lowest29.2850 USD
24h Price movement-0.91%
CLDX recent prices
24 Hours
-0.91%-$0.27
30 days
-7.67%-$2.455
60 days
-9.34%-$3.045
90 days
+0.12%+$0.035
Key data
Previous close29.6000 USD
Market cap2.25B USD
Volume490.42K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.6100 USD
Net income (FY)-283.65M USD
Revenue (FY)866.00K USD
Last report dateMay 7, 2026
About Celldex Therapeutics, Inc
HeadquartersHAMPTON
Employees (FY)198.00
Revenue per employee (FY)4.37K USD
Net income per employee (FY)-1.43M USD
Listed onNasdaq
CLDX conversion tables
 |  |
|---|---|
| 0.5 CLDX | 14.66 USD |
| 1 CLDX | 29.33 USD |
| 5 CLDX | 146.65 USD |
| 10 CLDX | 293.3 USD |
| |
|---|---|
| 0.5 USD | 0.017047 CLDX |
| 1 USD | 0.034095 CLDX |
| 5 USD | 0.17047 CLDX |
| 10 USD | 0.34095 CLDX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CLDX is trading at $29.33, -0.91% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CLDX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CLDX is currently trading at $29.33, -0.91% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CLDX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CLDX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CLDX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CLDX's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Celldex Therapeutics, Inc's market cap is currently 2.25B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume490.42K
24h highest30.3450 USD
24h lowest29.2850 USD
24h Price movement-0.91%
Start trade with CLDX Perpetual
Sign up to trade